Global Biologics Market Size and Segments
March 27, 2019 11:00 ET
|
The Business Research Company
LONDON, March 27, 2019 (GLOBE NEWSWIRE) -- A report from The Business Research Company shows that the global biologics market size is expected to reach around $319 billion by 2021 at an annual...
Biosimilars Market To Reach USD 44.56 Billion By Year 2026 | Reports And Data
March 19, 2019 11:34 ET
|
Reports And Data
Market Size – USD 5.10 Billion in 2018, Market Growth - CAGR of 30.8%, Market Trends – Product launches and research for advanced Biosimilars NEW YORK, March 19, 2019 (GLOBE NEWSWIRE) -- ...
IMRALDI™, Biogen’s Adalimumab Biosimilar Referencing Humira®, Is Launched in the European Union
October 17, 2018 02:00 ET
|
Biogen Inc.
IMRALDITM is approved in the European Union for the same 14 complex autoimmune conditions as its reference product In 2017 Biogen became the first company in Europe with approved biosimilars...
American College of Rheumatology Urges HHS to Adopt Drug Policy Principles that Protect Health Care Access for Chronically Ill Americans
June 12, 2018 08:38 ET
|
American College of Rheumatology
Washington, D.C., June 12, 2018 (GLOBE NEWSWIRE) -- In response to the Trump Administration’s American Patients First drug pricing blueprint, the American College of Rheumatology – which represents...
Momenta Pharmaceuticals to Webcast Presentation at the Bank of America Merrill Lynch Health Care Conference 2018
May 10, 2018 08:00 ET
|
Momenta Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 10, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 08, 2018 07:01 ET
|
Momenta Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the first quarter ended March 31, 2018 and provided a...
Biosimilars Market to See 30.5% Annual Growth Through 2022
April 16, 2018 06:00 ET
|
BCC Research
WELLESLEY, Mass., April 16, 2018 (GLOBE NEWSWIRE) --
An increase in the aging population, rising incidences of various diseases and increasing pressure to cut healthcare costs are driving...
The American College of Rheumatology Recommends Biosimilar Use in New White Paper
February 07, 2018 15:57 ET
|
American College of Rheumatology
Atlanta, Feb. 07, 2018 (GLOBE NEWSWIRE) -- The American College of Rheumatology (ACR) has published a new white paper, “The Science Behind Biosimilars – Entering a New Era of Biologic Therapy,”...
Rheumatology Leaders to HHS: Prior Authorization, Recent Part B Payment Change are Biggest Threats to Healthcare Choice and Competition
January 30, 2018 14:13 ET
|
American College of Rheumatology
Washington, DC, Jan. 30, 2018 (GLOBE NEWSWIRE) -- In its response to the U.S. Department of Health and Human Services’ latest Request for Information on Promoting Health Care Choice and Competition...
109 Healthcare Groups Urge Congress to Immediately Reverse CMS Policy Linking Physician Payment Adjustments to Part B Drug Costs
January 18, 2018 15:43 ET
|
American College of Rheumatology
Washington, DC, Jan. 18, 2018 (GLOBE NEWSWIRE) -- More than 100 of the nation’s leading patient and provider organizations – including the American College of Rheumatology – are urging Congressional...